Stock Research for XRTX

XRTX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

XRTX Stock Chart & Research Data

The XRTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the XRTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


XRTX Due diligence Resources & Stock Charts

The XRTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View XRTX Detailed Price Forecast - CNN Money CNN View XRTX Detailed Summary - Google Finance
Yahoo View XRTX Detailed Summary - Yahoo! Finance Zacks View XRTX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View XRTX Trends & Analysis - Trade-Ideas Barrons View XRTX Major Holders - Barrons
NASDAQ View XRTX Call Transcripts - NASDAQ Seeking View XRTX Breaking News & Analysis - Seeking Alpha
Spotlight View XRTX Annual Report - CompanySpotlight.com OTC Report View XRTX OTC Short Report - OTCShortReport.com
TradeKing View XRTX Fundamentals - TradeKing Charts View XRTX SEC Filings - Bar Chart
WSJ View Historical Prices for XRTX - The WSJ Morningstar View Performance/Total Return for XRTX - Morningstar
MarketWatch View the Analyst Estimates for XRTX - MarketWatch CNBC View the Earnings History for XRTX - CNBC
StockMarketWatch View the XRTX Earnings - StockMarketWatch MacroAxis View XRTX Buy or Sell Recommendations - MacroAxis
Bullish View the XRTX Bullish Patterns - American Bulls Short Pains View XRTX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View XRTX Stock Mentions - StockTwits PennyStocks View XRTX Stock Mentions - PennyStockTweets
Twitter View XRTX Stock Mentions - Twitter Invest Hub View XRTX Investment Forum News - Investor Hub
Yahoo View XRTX Stock Mentions - Yahoo! Message Board Seeking Alpha View XRTX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for XRTX - SECform4.com Insider Cow View Insider Transactions for XRTX - Insider Cow
CNBC View XRTX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for XRTX - OTC Markets
Yahoo View Insider Transactions for XRTX - Yahoo! Finance NASDAQ View Institutional Holdings for XRTX - NASDAQ


Stock Charts

FinViz View XRTX Stock Insight & Charts - FinViz.com StockCharts View XRTX Investment Charts - StockCharts.com
BarChart View XRTX Stock Overview & Charts - BarChart Trading View View XRTX User Generated Charts - Trading View




Latest Financial News for XRTX


XORTX Announces Publication of Key Research in ADPKD
Posted on Monday April 22, 2024

CALGARY, Alberta, April 22, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce a research paper titled “Raising serum uric acid with a uricase inhibitor worsens PKD in rat and mouse models" has been accepted for publication in the peer-reviewed American Journal of Phys


XORTX Welcomes New Member to the Board of Directors
Posted on Monday April 08, 2024

CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, welcomes Abigail Jenkins, a biotech industry veteran with deep experience with the commercialization of therapies for renal and cardiovascular disease, to its Board of Directors. Abigail “Abbey” L. Jenkins, M.S.,


XORTX Announces Participation in Spring 2024 Investor Conferences
Posted on Monday April 08, 2024

CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that Dr. Allen Davidoff, CEO, is scheduled to participate in the following Spring 2024 investor and life sciences investment conferences: LD Micro Invitational XIV in New York, April 8-9Management will d


XORTX Announces New Clinical Advisory Board Member
Posted on Wednesday March 27, 2024

CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a biopharmaceutical company focused on developing innovative therapies to treat autosomal dominant polycystic kidney disease (“ADPKD”), is pleased to announce that Dr. Ronald Perrone has joined the Company’s Clinical Advisory Board. Dr. Allen Davidoff stated, “We are excited that Dr. Ron Perrone has agreed to join XORTX’s Clinical Advis


Stock Market & Investing Books

Enter a stock symbol to view the stock details.